Innovation Workshop Series – Introductory Course

9 jun 15

Technology transfer: turning academic results into business opportunities by Marc Ramis Castelltort, CEO at Tech & Business Innovation (TBI)

L'equip d'innovació de l'IRB Barcelona reforça els vincles amb la indústria.

Presentation

Organizer: IRB Innovation Department
Date: Tuesday June 9, 11:00-13:00
Place: Aula Fèlix Serratosa, Parc Científic de Barcelona, Spain
Level/Language: Introductory / English

Fundamentals and key elements of technology transfer by the hand of Marc Ramis, CEO at Tech & Business Innovation (TBI). How to translate academic results to the private biomedical sector.

Have you ever wonder about:

What is Technology Transfer? Is it related to the actitivies in my lab? How?
What happens when we get a great result? Will it reach society? How?
What do the terms CEO, Business Angel, Elevator Pitch, Business Plan, Go-to-market Strategy mean?

If you love science and are curious about what happens after you get a remarkable result, then this workshop is for you. Also, if you are motivated to generate employment opportunities in the private biomedical sector through your discoveries, you will find this workshop highly informative.

The workshop is offered exclusively to IRB members and limited to 45 participants.

To register, please send an email with your name, lab and position to alba.olivares@irbbarcelona.org by Tuesday, 26 May.

Speakers

Marc Ramis Castelltort, CEO at Tech & Business Innovation (TBI)
Marc is an entrepreneurial business developer focused on science commercialization and innovation management. He is the CEO of Tech & Business Innovation (TBI), an academic firm focused on knowledge exchange and corporate-academic partnerships. Also, Marc is a strategic advisor and board member for multiple organizations and a co-founder of several companies. From 2010 to 2012, Marc was working for Isis Innovations/University of Oxford as an associate consultant in Spain and LATAM. From 2007 to 2011, Marc was working at Endor, a nanomedicine company based in Spain. During this period, he was R&D director (drug-delivery nanosystems for cancer therapy) and Business Development director (launched several nanotechnology products to the cosmetic and textile markets).

Previously, Marc also worked in the pharmaceutical environment in Novartis. He also collaborated with other research institutions such as Cancer Research UK and Boston College during his academic career. Marc gained a DPhil in Biochemistry from the University of Oxford in 2006, and a Harvard Business School PLD Program in 2011. Marc also gained a M.Sc. in Chemical Engineering in 2001 and a B.Sc. in Chemistry from IQS (Barcelona) in 2000.